Rheumatologic Disorder
Conditions
Brief summary
Patients new to a rheumatology practice will be asked if they want to consent to their blood sample, medical records, and hand/foot x-rays (with sharp scores) for the analysis and correlation with the diagnosis they will receive from the rheumatologist.
Detailed description
At the end of their first visit new rheumatology patients will be asked for their interest in joining the Inova biomarker study. If yes, the patient will be consented, blood will be drawn for the Inova biomarkers, and x-rays will be sent for sharp scoring. Patients may decline and will not be part of the Inova study. Patients who decline will continue to receive standard of care treatment henceforth. Patients in the Inova trial will receive a diagnosis from their doctor and are placed into separate cohorts based upon their diagnosis. The Inova biomarker results of each cohort will be cross-correlated with diagnoses, pre-screening tool results. Baseline disease activity and sharp scores will also be correlation variables.
Interventions
OTHERThere is no intervention, but a diagnosis.
Cohorts will be determined by the primary rheumatology diagnosis.
Sponsors
Inova Diagnostics Inc
Bristol-Myers Squibb
University of Nebraska
Arthritis Northwest PLLC
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* Newly referred Arthritis Northwest PLLC * Age 18 or older
Exclusion criteria
* None.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The correlation between novel biomarkers and the primary rheumatology diagnosis | 18 month enrollment period. No follow-up period | Pearson's correlation coefficient of each biomarker to each cohort |
Contacts
Primary ContactTerri Cone
Backup ContactBonnie Burgess
Outcome results
None listed